Chromosome 6 deletions are rare genetic conditions in which a segment of chromosome 6 is missing, leading to a wide and variable spectrum of developmental, physical, and neurological problems. Because chromosome 6 is one of the larger human chromosomes and carries hundreds of genes, the specific effects depend heavily on which portion is deleted and how large the missing segment is. These deletions can occur on the short arm (designated 6p) or the long arm (6q), and the distinction matters enormously for what symptoms a person will experience, which genes are lost, and how physicians approach care.
How Chromosome 6 Deletions Happen
Most chromosome 6 deletions arise spontaneously during the formation of eggs or sperm, or very early in embryonic development. These are called de novo events, meaning neither parent carries the same deletion. The breakage can happen at virtually any point along the chromosome, which is why two people with a “chromosome 6 deletion” can have strikingly different clinical pictures.
In a smaller number of cases, a parent carries what geneticists call a balanced translocation, where pieces of two chromosomes have swapped places without any net loss of genetic material. The parent is usually healthy because all the genes are still present, just rearranged. But when that parent’s chromosomes are passed to a child, the rearrangement can become unbalanced, resulting in a deletion on one chromosome and sometimes an extra copy of material from another. One documented case involved a mother with a balanced translocation between chromosomes 6 and 10; her child inherited a derivative chromosome 6 that was missing material from the short arm (6p23 to the tip) while carrying extra material from chromosome 10.1PubMed Central. Clinical Expression of an Inherited Unbalanced Translocation in Chromosome 6 That kind of inheritance pattern means that once a deletion is identified in a child, testing both parents can clarify whether the event was random or whether future pregnancies carry a measurable recurrence risk.
Some deletions are “terminal,” meaning the break occurs near the tip of the chromosome arm and everything beyond that break is lost. Others are “interstitial,” meaning a segment from the middle of the arm is removed while the tip remains intact. Terminal and interstitial deletions of the same chromosome arm can produce quite different clinical presentations because different genes are involved.
Short Arm (6p) Deletions
The short arm of chromosome 6, labeled 6p, contains genes important for brain development, eye formation, and immune function. When a piece of 6p is missing, the effects often include developmental delay, intellectual disability, and subtle facial differences. A case involving a 2.5-megabase interstitial deletion in the 6p22.3 region, which spanned 13 genes, resulted in developmental delay and mild dysmorphic features in a child.2BioMed Central / Europe PMC. Partial deletion of chromosome 6p causing developmental delay and mild dysmorphisms in a child: molecular and developmental investigation and literature search Larger deletions in the 6p22–p24 region have been linked to more severe outcomes, including autism spectrum disorders, seizures, heart defects, and speech delay.3BioMed Central / Molecular Cytogenetics. Deletions in chromosome 6p22.3-p24.3, including ATXN1, are associated with developmental delay and autism spectrum disorders
Eye abnormalities deserve special mention in the context of 6p deletions. Deletions near the tip of 6p, at band 6p25, can disrupt the FOXC1 gene, which plays a central role in the development of the front structures of the eye. Loss of one copy of FOXC1 has been associated with Axenfeld-Rieger anomaly, a condition involving malformation of the iris and drainage structures of the eye that carries a significant risk of glaucoma.4Investigative Ophthalmology & Visual Science. Ocular Developmental Abnormalities and Glaucoma Associated with Interstitial 6p25 Duplications and Deletions For families dealing with a 6p25 deletion, early and regular eye exams become a priority, because untreated glaucoma can lead to progressive vision loss.
Long Arm (6q) Deletions
Deletions on the long arm of chromosome 6 are better characterized in the medical literature, partly because they tend to produce more clinically recognizable patterns. The clinical picture is broad. A large cohort study drawing on both published case reports and social media communities identified a common set of features in terminal 6q deletions: microcephaly, unusually shaped ears, widely spaced eyes, vision problems, feeding difficulties, recurrent infections, brain abnormalities including enlarged ventricles and corpus callosum malformations, seizures, low muscle tone, developmental delay, sleep disturbances, and hyperactivity.5PubMed Central. The phenotypic spectrum of terminal 6q deletions based on a large cohort derived from social media and literature: a prominent role for DLL1 Congenital heart defects, kidney problems, scoliosis, and spina bifida are also frequently reported in that same cohort.
A separate literature review cataloged an overlapping but slightly different list of features, emphasizing craniofacial anomalies like a thin upper lip and downturned mouth corners, along with muscle weakness, cardiac disorders, and cognitive impairment to varying degrees.6PubMed Central. Clinical and genetic features of 6q deletion syndrome: A literature review and case report One consistent theme across studies is that no two children present identically, even when their deletions overlap. The severity of intellectual disability, for instance, ranges from mild learning difficulties to profound impairment, depending on which and how many genes are lost.
The brain malformations seen in terminal 6q deletions have been linked to the DLL1 gene, which sits near the end of 6q and plays a role in brain patterning during fetal development. Loss of DLL1 produces structural brain anomalies that closely resemble those seen in people with point mutations in the same gene, which strengthened the case that DLL1 is a major driver of the neurological features.7PubMed. Terminal 6q deletions cause brain malformations, a phenotype mimicking heterozygous DLL1 pathogenic variants: A multicenter retrospective case series
Interstitial Versus Terminal 6q Deletions
The distinction between terminal and interstitial deletions on the long arm turns out to be clinically relevant beyond just gene content. Terminal 6q deletions tend to produce recognizable clusters of symptoms, particularly the brain malformations and seizure patterns described above. In a study of five patients with terminal 6q deletions, all experienced seizures characterized by vomiting, cyanosis, and head turning, and brain imaging showed consistent patterns including abnormal development of the corpus callosum and brainstem.8PubMed. 6q terminal deletion syndrome associated with a distinctive EEG and clinical pattern: a report of five cases
Interstitial 6q deletions, by contrast, have not shown a similarly distinctive clinical or neurological pattern.9Seizure: European Journal of Epilepsy. Interstitial 6q deletion in a patient presenting with drug-resistant epilepsy and Prader-Willi like phenotype: An electroclinical description with literature review Their clinical effects are more variable and harder to predict, since the missing segment can come from many different locations along the long arm. This unpredictability makes counseling families more challenging when an interstitial deletion is found, because the published literature on any specific breakpoint combination is thin.
Key Genes and the Conditions They Drive
One of the reasons chromosome 6 deletions produce such varied symptoms is that individual genes within the deleted region can each contribute distinct medical problems. Several genes on chromosome 6 have been singled out as particularly consequential when they are lost.
SIM1 and Obesity
The SIM1 gene, located on the long arm of chromosome 6 near band 6q16, encodes a protein involved in the development of the hypothalamus, the brain region that regulates hunger and energy balance. Deletions that include SIM1 cause a form of severe early-onset obesity that closely mimics Prader-Willi syndrome, a much better-known genetic obesity condition caused by problems on chromosome 15.10PubMed. Endocrine phenotype of 6q16.1-q21 deletion involving SIM1 and Prader-Willi syndrome-like features Children with SIM1-encompassing deletions typically develop insatiable appetite, rapid weight gain, and may also show pituitary hormone deficiencies that compound growth and metabolic problems.11PubMed Central. Severe early onset obesity and hypopituitarism in a child with a novel SIM1 gene mutation Recognizing the SIM1 connection matters practically, because these children benefit from the same aggressive dietary and behavioral interventions used in Prader-Willi syndrome, and their endocrine status needs careful monitoring.
ARID1B and Coffin-Siris Syndrome
Toward the other end of the long arm, at band 6q25, the ARID1B gene has emerged as a key driver of intellectual disability associated with 6q deletions. ARID1B is the gene responsible for Coffin-Siris syndrome type 1, a condition characterized by developmental delay, speech impairment, distinctive facial features, absence or underdevelopment of the corpus callosum, limb anomalies, and hearing loss.12PubMed. Interstitial 6q25 microdeletion syndrome: ARID1B is the key gene In one particularly informative case, a girl presenting with the full constellation of 6q microdeletion syndrome features was found to carry a deletion spanning only about 1.1 megabases of DNA that contained just one coding gene: ARID1B. That finding strongly suggested ARID1B alone can account for many of the features attributed to larger 6q25 deletions.13PubMed Central. Identification of de novo mutations for ARID1B haploinsufficiency associated with Coffin–Siris syndrome 1 in three Chinese families via array-CGH and whole exome sequencing
PLAGL1 and Transient Neonatal Diabetes
A gene at 6q24 called PLAGL1 (also known as ZAC) is involved in a very different kind of problem. PLAGL1 is an imprinted gene, meaning only the copy inherited from the father is normally active. Disruptions at this locus, whether through deletion, duplication of the paternal copy, or changes in the chemical marks that control imprinting, can cause transient neonatal diabetes mellitus, a condition in which newborns develop diabetes within the first weeks of life.14PubMed. The cell cycle control gene ZAC/PLAGL1 is imprinted–a strong candidate gene for transient neonatal diabetes The diabetes typically resolves in infancy but can recur later in life. Because the mechanism involves imprinting rather than straightforward gene loss, the inheritance pattern is more complex than for most other genes in the region.15PubMed. 6q24 transient neonatal diabetes
How Chromosome 6 Deletions Are Diagnosed
Historically, chromosome 6 deletions were found through standard karyotyping, which involves staining and examining chromosomes under a microscope. This method can detect large deletions visible at the level of a chromosome band, but it misses smaller losses. The shift to array-based comparative genomic hybridization (array CGH) and similar microarray technologies dramatically improved the ability to detect submicroscopic deletions. In a study comparing the two methods, molecular breakpoints differed from those estimated by conventional karyotyping in two out of three cases, demonstrating how much more precise the newer technology is.16PubMed. Interstitial deletions of chromosome 6q: genotype-phenotype correlation utilizing array CGH Today, chromosomal microarray is typically the first-line test for a child with unexplained developmental delay, intellectual disability, or multiple congenital anomalies.
Prenatal detection is also possible. Amniocentesis or chorionic villus sampling can provide fetal cells for microarray analysis when ultrasound findings raise concern. In some cases, noninvasive prenatal screening using cell-free fetal DNA in the mother’s blood can flag large chromosomal imbalances, though it is less reliable for small deletions and is considered a screening rather than a diagnostic tool. When a deletion is found prenatally, families face difficult decisions, and genetic counseling becomes essential to help them understand the range of possible outcomes.
Once a deletion is confirmed, identifying the exact boundaries and the genes within the deleted segment is the most useful next step. Knowing whether SIM1, ARID1B, FOXC1, DLL1, or PLAGL1 is involved can focus medical surveillance and connect the family with condition-specific resources and research communities.
Treatment and Management
There is no cure for a chromosome 6 deletion, and no standardized treatment protocol exists for managing these conditions. Care is driven entirely by the individual symptoms each person presents with.17PubMed Central. Clinical and genetic features of 6q deletion syndrome: A literature review and case report – Section: Therapeutic intervention In practice, this means a team-based approach in which multiple specialists each address their part of the clinical picture.
Common interventions include:
- Nutritional support: Many infants with chromosome 6 deletions have feeding difficulties, failure to thrive, or both. Specialized feeding strategies, and sometimes tube feeding, may be needed in the early months or years.
- Physical therapy: Low muscle tone and motor delays are common, and early motor therapy can improve milestones like sitting, standing, and walking.
- Speech and cognitive therapy: Tailored speech therapy and developmental programs support language acquisition and cognitive development, though goals and timelines vary widely depending on the severity of intellectual disability.
- Seizure management: Anti-seizure medications are used when epilepsy is present, though some individuals with chromosome 6 deletions have drug-resistant seizures that require additional strategies.
- Cardiac monitoring: Children with congenital heart defects may need surgical intervention or long-term cardiology follow-up.
- Ophthalmologic care: For those with 6p25 deletions involving FOXC1, regular glaucoma screening and treatment of any detected eye abnormalities are critical.
- Endocrine management: When SIM1 is deleted, monitoring for obesity and pituitary hormone deficiency guides interventions including dietary management and possible hormone replacement therapy.
The reality of living with a chromosome 6 deletion often revolves around coordinating all of these specialists, something that falls largely on families. Many parents find that connecting with other families through online communities and advocacy organizations provides practical guidance that medical teams sometimes cannot, from tips on which therapies have been most helpful to navigating school accommodations.
When Dysmorphic Features and Heart Defects Overlap
Congenital heart disease deserves its own discussion because it appears across both 6p and 6q deletions and can be the most immediately life-threatening consequence. A report of a child with a terminal 6q deletion documented the combination of congenital heart disease, intellectual disability, and distinctive facial features that has become a recognizable presentation in this deletion group.18PubMed Central. Dysmorphic features and congenital heart disease in chromosome 6q deletion: A short report Heart defects in chromosome 6 deletion patients range from minor septal defects that close on their own to complex structural malformations requiring surgical repair in infancy. Because heart problems are not present in every case, echocardiography early in life is a standard recommendation for any child diagnosed with a chromosome 6 deletion, regardless of whether symptoms are apparent.
Facial features associated with chromosome 6 deletions are typically subtle rather than dramatic. They often include a flat midface, a thin upper lip, low-set or unusually shaped ears, and widely spaced eyes. These features, individually, are common enough in the general population that they do not automatically suggest a genetic diagnosis. It is usually the combination of facial findings with developmental delay or organ abnormalities that prompts genetic testing.
Why No Two Cases Look the Same
Families who receive a chromosome 6 deletion diagnosis often search for other people with the same condition and are surprised by how different two children with seemingly similar deletions can be. Several factors explain this variability. The most obvious is deletion size: losing 1 megabase of DNA removes far fewer genes than losing 10 megabases, so larger deletions generally produce more severe and more numerous symptoms. But even deletions of similar size can differ in their consequences depending on exactly where the breakpoints fall and which genes are disrupted.
Beyond that, the remaining copy of chromosome 6 matters. If the intact copy carries variants in the same genes that subtly reduce their function, the effect of losing the other copy may be amplified. Environmental factors during pregnancy and early development also play a role that is difficult to quantify. And for imprinted genes like PLAGL1, whether the deletion affects the maternally or paternally derived chromosome determines whether there is a clinical effect at all.
This variability is both frustrating and, in a sense, hopeful. It means that a given deletion does not dictate a single, fixed outcome. Some children with chromosome 6 deletions attend mainstream school with supports; others require more intensive services. Predicting where any individual child will land on that spectrum remains one of the hardest aspects of counseling families after a diagnosis, and it is an area where gathering larger patient cohorts through registries and social media communities is slowly improving the quality of prognostic information available.
Transient Neonatal Diabetes and Later Metabolic Risk
The PLAGL1-related transient neonatal diabetes that arises from changes at 6q24 is one of the more distinctive conditions associated with chromosome 6. Affected infants are typically born small for gestational age and develop high blood sugar within the first few weeks of life. Insulin treatment is required initially, but the diabetes resolves on its own, usually within the first year. What catches many families off guard is that the condition can return in adolescence or early adulthood, sometimes as a form of diabetes that resembles type 2. The mechanism behind this relapse is not fully understood, but the temporary nature of the neonatal episode followed by the risk of recurrence makes long-term metabolic monitoring advisable for anyone diagnosed with transient neonatal diabetes linked to 6q24.
Because transient neonatal diabetes can occur through several different genetic and epigenetic mechanisms at the same chromosomal locus, the specific molecular cause determines whether siblings are at risk. In some families the condition is inherited; in others it arises sporadically.15PubMed. 6q24 transient neonatal diabetes Genetic testing can distinguish between these scenarios and guide family planning decisions.